Search In this Thesis
   Search In this Thesis  
العنوان
The immunomodulatory effects of probiotic bacteria on peripheral blood mononuclear cells (PBMCs) of allergic patients /
المؤلف
Metwally, Wafaa Salah Abdelhaleem.
هيئة الاعداد
باحث / وفاء صلاح عبد الحليم متولي
مشرف / منى أحمد شلبي
مشرف / سمية محمد الشيخ
مشرف / راغدة عبد اللطيف حافظ
الموضوع
Probiotics. Allergie- patients.
تاريخ النشر
2014.
عدد الصفحات
174 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب
الناشر
تاريخ الإجازة
1/1/2014
مكان الإجازة
جامعة الزقازيق - كلية الطب البشرى - Microbiology and Immunology
الفهرس
Only 14 pages are availabe for public view

from 204

from 204

Abstract

In this study we showed that Lactobacillus rhamnosus ATCC 7469 strain can modulate the TH1/TH2 balance by reducing TH2 cytokine (IL4) release and enhancing TH1 cytokine production (IFN-γ). The same effect was also obtained by the C-phycocyanin, pigmented extract from the cyanobacterium Spirulina platensis. The mechanism by which Lactobacillus rhamnosus exerted this effect seemed to be their cell wall composition, as the results obtained by dead bacteria were similar to those obtained by the living ones. The safety of lactobacilli is very good; it could be a future treatment for allergy. As the best anti-allergic effects of these bacteria was obtained when acting in absence of the allergen, it is better to use this bacteria in the prophylaxis rather than in treatment of allergic attacks. As the bacteria gave quite similar results in patients and healthy subjects, we assume that it could be a permissive line of prevention of allergy.
The effect of C-PC was very good for the allergic group as it induced IFN-γ and decreased IL4, so, it could be considered as a line of prevention of allergic attacks in atopic individuals .However, It induced considerable IL4 levels in control group, but still the most potent IFN-γ inducer in this group, so, it needs further investigation for its value in healthy subjects. As Spirulina platensis and its content C-phycocyanin are generally safe , they could be a new promising anti allergic therapy.